Viés de alta
LONG $XXII BASED ON NEWS AND OPTIONS ACTIVITY
GREAT TECHNICAL SETUP WITH INSTITUTIONAL BUYERS COMING IN
BUILD A LONG TERM POSITION AMEX:XXII
GREAT PULL BACK TODAY AND CHANCE TO GET IN AROUND $3 LEVEL
It received a major boost because of commentary from the Food and Drug Administration on July 28 that called for a new comprehensive plan on tobacco and nicotine regulation. The quick summary of the FDA's press release: It called for a reduction in nicotine in cigarettes to non-addictive levels, which would play right into the hands of 22nd Century Group, as a biotech company focused on reducing nicotine levels in tobacco.
BUILD A LONG TERM POSITION AMEX:XXII
GREAT PULL BACK TODAY AND CHANCE TO GET IN AROUND $3 LEVEL
It received a major boost because of commentary from the Food and Drug Administration on July 28 that called for a new comprehensive plan on tobacco and nicotine regulation. The quick summary of the FDA's press release: It called for a reduction in nicotine in cigarettes to non-addictive levels, which would play right into the hands of 22nd Century Group, as a biotech company focused on reducing nicotine levels in tobacco.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.